Abstract
As potential blood-contact biomaterials, the biocompatibility of siloxane-based PCUs was further improved by inserting sulfobetaine as demonstrated by the markedly retarded fibrinogen absorption on and platelet adhesion to their surface.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have